SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-126268
Filing Date
2024-11-13
Accepted
2024-11-13 16:00:25
Documents
70
Period of Report
2024-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q isco-20240930.htm   iXBRL 10-Q 1836246
2 EX-31.1 isco-ex31_1.htm EX-31.1 12361
3 EX-31.2 isco-ex31_2.htm EX-31.2 12333
4 EX-32.1 isco-ex32_1.htm EX-32.1 7531
5 EX-32.2 isco-ex32_2.htm EX-32.2 8100
  Complete submission text file 0000950170-24-126268.txt   9108651

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT isco-20240930.xsd EX-101.SCH 1102355
73 EXTRACTED XBRL INSTANCE DOCUMENT isco-20240930_htm.xml XML 2010274
Mailing Address 9745 BUSINESSPARK AVENUE SAN DIEGO CA 92131
Business Address 9745 BUSINESSPARK AVENUE SAN DIEGO CA 92131 760-940-6383
International Stem Cell CORP (Filer) CIK: 0001355790 (see all company filings)

IRS No.: 204494098 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-51891 | Film No.: 241453812
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)